System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Graham A Colditz is an expert in Oncology at Washington University Medical Center (United States). As of October 2026, ScienceLeadR ranks Graham A Colditz in the top 1% of experts worldwide for Breast Diseases, Breast Neoplasms and Epidemiologic Studies. Graham A Colditz has authored 1,644 publications, the most recent in 2026, and is an investigator in 21 clinical trials, 3 of them ongoing. SLR score: 5,942 (community average: 125). How the SLR is computed.

LeadR Profile

Graham A Colditz Washington University Medical Center United States
5 942 ScienceLeadR Reputation 5942

Unlock

Register Login
Network Map

Oncology

Subspecialties: Public Health - Hematology - Nutrition

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1983 - 2026
Source: PubMed

Brigham and Women's Hospital

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 1644

Citations

Citations: 255 335 1st author: 98 Last author: 402 Unique author: 60

Main journals

Cancer Epidemiol Biomarkers Prev 108
Cancer Res 83
Am J Epidemiol 74
Cancer Causes Control 74
J Natl Cancer Inst 72

Best Journals

JAMA 64
N Engl J Med 41
J Clin Oncol 10

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Breast Cancer Risk After Benign Breast Disease Among Racially Diverse Women: Systematic Review and Meta-Analysis.
PMID 42620475 — breast neoplasms, neoplasms, breast, breast diseases		Res Sq20260
Association between diabetic control and progression of monoclonal gammopathy of undetermined significance to multiple myeloma.
PMID 42581042 — diabetes mellitus, multiple myeloma, monoclonal gammopathy of undetermined significance		Blood Cancer J20260
Trends in awareness and uptake of genetic testing among the United States population, 2011-2022.
PMID 42573648 — research design, genetic testing, neoplasms, income, history		J Community Genet20260
Extracellular Matrix Proteomic Signatures Associate with Disease-Free Survival in Later Events of Ductal Carcinoma In Situ or Invasive Breast Cancer.
PMID 42539300 — cells, disease-free survival, breast neoplasms, carcinoma, ductal, neoplasms, collagen, carcinoma, intraductal, noninfiltrating, breast, proteome, extracellular matrix, carcinoma in situ		bioRxiv20260
Reliability of stromal markers multiplex immunofluorescent staining: pathologist assessment compared to quantitative image analysis.
PMID 42266734 — pathologists, neoplasms, breast, tissues		Am J Cancer Res20260

Clinical Studies 21

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 3

By phase:

N/A 20
Phase 1 1

By status:

Completed 13
Recruiting 5
Active not recruiting 1
Terminated 1
Unknown 1

By type:

Interventional 18
Observational 3

By Monocentric/Multicentric:

monocentric 13
multicentric2to4 3
multicentric5to9 5
multicentricup10 0

Main Topics

Ongoing Clinical Trials

3 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Precision Supplemental Imaging in Women With Dense Breasts
NCT07277738 — epidemiology, breast neoplasms, incidence, risk assessment, neoplasms, magnetic resonance imaging, mammography, algorithms, breast, women		N/ARecruiting2026
Interdisciplinary Group Care for the Treatment of Endometriosis associated Pain
NCT06549985 — endometriosis, quality of life, pilots, pain, mindfulness, pelvic floor, surveys and questionnaires, pelvic pain, therapeutics, education, educational status		N/ARecruiting2025
Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU PE CGS)
NCT06340646 — cells, research design, genetic testing, neoplasms, colon, biomarkers, multiple myeloma, rectal neoplasms, colorectal neoplasms, mutation, universities, cholangiocarcinoma, colonic neoplasms		N/ARecruiting2022

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS